Hong Kong Healthtech Stock News

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has drawn fresh attention after reporting a shift to profitability in its half year 2026 results, along with a series of product milestones across its oncology portfolio. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The recent run of clinical milestones, regulatory decisions and the shift to profitability appears to have supported sentiment in Sichuan Kelun-Biotech Biopharmaceutical, with the stock delivering a 13.45%...

Ping An Healthcare and Technology (SEHK:1833) reported half year 2026 earnings with sales of CNY 2,483.83 million and net income of CNY 219.33 million, alongside basic and diluted EPS of CNY 0.10. See our latest analysis for Ping An Healthcare and Technology. The earnings release on 18 August has come after a weak stretch for Ping An Healthcare and Technology, with the share price at HK$6.735 and the year-to-date share price return down 53.81%, while the 3-year total shareholder return is...

China Risun Group (SEHK:1907) issued new earnings guidance for the first half of 2026, saying net profit is expected to be at least 335% above the prior year period, driven mainly by wider refined chemical price spreads. See our latest analysis for China Risun Group. At a share price of HK$1.985, China Risun Group has seen short term momentum pick up, with a 7 day share price return of 7.88%. However, the 1 year total shareholder return is down 17.84%, which points to weaker longer term...

TCL Electronics Holdings (SEHK:1070) put its AI driven entertainment and connected living lineup in the spotlight at IFA 2026, unveiling SQD-Mini LED displays, NXTPAPER devices, RayNeo smart glasses and refreshed smart home appliances. See our latest analysis for TCL Electronics Holdings. These AI focused product launches arrive after a strong run for TCL Electronics Holdings, with the share price now at HK$15.99 and a year to date share price return of 52.72%. Over the same period, long term...

Half year earnings update and why Sino Biopharmaceutical stock is in focus Sino Biopharmaceutical (SEHK:1177) recently reported half year 2026 earnings, with sales of CNY 19,444.36 million and net income of CNY 3,434.6 million. Earnings per share from continuing operations also edged higher versus a year earlier. See our latest analysis for Sino Biopharmaceutical. The latest earnings release appears to have sharpened investor focus on Sino Biopharmaceutical, with the stock posting a 3.80% 1...

China Tower (SEHK:788) recently reported half year 2026 results and announced an interim cash dividend, giving investors fresh information on both earnings and shareholder payouts ahead of key September and October dates. See our latest analysis for China Tower. Despite the interim dividend and stronger half year earnings, China Tower's share price return has been mixed, with the stock up 1.63% over the last day but down 19.95% year to date. The 3 year total shareholder return of 36.74%...

After a long run where a handful of U.S. mega caps have dominated headlines, rising concentration risk, choppy sector leadership and fresh geopolitical worries are pushing more investors to rethink where their income comes from. That shift is creating a window for real asset stocks that offer clearer cash flow stories. This article walks through three stocks from our global real asset income screener that appear closely tied to the latest news drivers. The three stocks highlighted below are...

Shanghai Electric Group (SEHK:2727) is back in focus after joining Shanghai International Port Group and CMA CGM Group on August 17 for what was described as the largest single biomethanol bunkering operation. See our latest analysis for Shanghai Electric Group. Despite the green fuel milestone, Shanghai Electric Group’s recent share price performance has been weak, with the 90 day share price return down 40.5% and the year to date share price return down 25.67%, even though the 5 year total...

How East Buy Holding’s latest earnings are shaping investor focus East Buy Holding (SEHK:1797) has drawn fresh attention after releasing full year results to May 31, 2026, reporting sales of CNY 5,701.01 million and net income of CNY 543.55 million. See our latest analysis for East Buy Holding. Alongside these earnings, East Buy Holding’s share price has fallen 12.62% over the past month and 11.24% over the past quarter, even though the year to date share price return is up 11.77% and the 5...

CSC Financial Co., Ltd. reported past half-year results for the period ended June 30, 2026, with revenue of CNY 16,228.81 million and net income of CNY 7,639.13 million, both higher than the same period a year earlier. Basic and diluted earnings per share from continuing operations rose to CNY 0.92 from CNY 0.52, highlighting stronger profitability on a per-share basis. With this sharp improvement in per-share earnings, we will now examine how the results shape CSC Financial’s broader...

Impro Precision Industries (SEHK:1286) drew investor attention after reporting half year 2026 sales of HK$3,018.05 million and net income of HK$421.04 million, alongside an interim dividend of HK$0.08 per share. See our latest analysis for Impro Precision Industries. The latest half year results and interim dividend seem to be feeding into strong momentum in Impro Precision Industries, with the share price at HK$9.0 and a year to date share price return of 77.87%. The 1 year total shareholder...

China Hongqiao Group (SEHK:1378) drew fresh attention after reporting half year 2026 results, with sales of CNY 87,505.9 million and net income of CNY 17,210.31 million, alongside higher earnings per share. See our latest analysis for China Hongqiao Group. Despite the recent half year results and the decision to redeem US$330.0m of notes, China Hongqiao Group’s 90 day share price return is down 21.74% and the year to date share price return is down 31.86%. However, the 3 year total...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

SINOPEC Engineering (Group) (SEHK:2386) has drawn fresh attention after announcing a new share repurchase plan of up to HK$150 million, alongside interim results showing higher sales but lower net income for the first half of 2026. See our latest analysis for SINOPEC Engineering (Group). Set against the new HK$150 million repurchase plan and a lower interim dividend, SINOPEC Engineering (Group)'s recent 1 day share price return of 2.48% contrasts with a year to date share price decline of...

Semiconductor Manufacturing International (SEHK:981) is back in focus after reporting second quarter 2026 earnings, with sales of US$3,005.59 million and net income of US$479.2 million, along with guidance for modest third quarter revenue growth. See our latest analysis for Semiconductor Manufacturing International. The latest earnings update and guidance appear to have supported Semiconductor Manufacturing International’s recent momentum, with a 7 day share price return of 2.40% and a softer...

While Symphony Holdings Limited ( HKG:1223 ) shareholders have enjoyed a good week with stock up 17%, they need remain...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Mokingran Jewellery Group Co., Ltd. ( HKG:2585 ) insiders who bought shares over the past year were rewarded handsomely...

Kwoon Chung Bus Holdings Limited ( HKG:306 ) is about to trade ex-dividend in the next 4 days. Typically, the...

Last week, you might have seen that China Resources Beer (Holdings) Company Limited ( HKG:291 ) released its...

Investors in Keymed Biosciences Inc. ( HKG:2162 ) had a good week, as its shares rose 2.8% to close at HK$80.30...

Last week, you might have seen that ZJLD Group Inc ( HKG:6979 ) released its interim result to the market. The early...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Zhuzhou CRRC Times Electric Co., Ltd. ( HKG:3898 ) just released its latest second-quarter report and things are not...